Av
Bolaget för diskussioner med flera olika bolag i Indien och Kina.
- Vi är på diskussionsstadiet och har skrivit vissa inldeande avtal kring konfidentialitet bland annat, säger den avgående vd:n Johan Järte.
Han menar att intresset från Asien är stort och han kommer att stanna i bolaget och bland annat sköta förhandlingarna med de asiatiska bolagen även efter det att Rune Bremberg tillträder som ny vd i mars.
Under våren 2010 kommer Sentoclone också att göra en nyemission. Det är dock inte bestämt ännu hur stort belopp de ska ta in, men pengarna behövs för möjligheten att i förlängningen skapa ett positivt kassaflöde, enligt Johan Järte.
- Pengarna ska användas till att föra fram nya produkter till registrering och därefter förhoppningsvis skapa ett positivt kassaflöde. Men allt beror ju på hur de kliniska studierna går, säger han.
De tidigaste resultaten att vänta gäller bilagets behandling mot malignt melanom och de väntas vara klara senast 2012. Första färdiga registreringen borde komma under 2013, enligt Johan Järte.
- Men man kan ju bara beställa kliniska studier, inte kliniska resultat, säger han.
- Vi är på diskussionsstadiet och har skrivit vissa inldeande avtal kring konfidentialitet bland annat, säger den avgående vd:n Johan Järte.
Han menar att intresset från Asien är stort och han kommer att stanna i bolaget och bland annat sköta förhandlingarna med de asiatiska bolagen även efter det att Rune Bremberg tillträder som ny vd i mars.
Under våren 2010 kommer Sentoclone också att göra en nyemission. Det är dock inte bestämt ännu hur stort belopp de ska ta in, men pengarna behövs för möjligheten att i förlängningen skapa ett positivt kassaflöde, enligt Johan Järte.
- Pengarna ska användas till att föra fram nya produkter till registrering och därefter förhoppningsvis skapa ett positivt kassaflöde. Men allt beror ju på hur de kliniska studierna går, säger han.
De tidigaste resultaten att vänta gäller bilagets behandling mot malignt melanom och de väntas vara klara senast 2012. Första färdiga registreringen borde komma under 2013, enligt Johan Järte.
- Men man kan ju bara beställa kliniska studier, inte kliniska resultat, säger han.
"Your work is important to us, we are committed to your success.
Innovative tools? Please download the Promega app." 
"As a full service CRO with offices in all Nordic countries we can provide our customer with professional support throughout the clinical research." 
"Medivir is a specialty pharmaceutical company with unique positioning on the Nordic market and our goal is become a profitable company in high growth" 
"To adapt Competent Authorities´ requirements into opportunities is not just an artform - today it´s a business necessity." 
"To supply Swedish and Danish laboratories with laboratory equipment and furniture of highest quality and offer service on all delivered products." 
"APL provides high-quality services to Life Science. We are a Dedicated Partner from Discovery to Market." 
"To develop innovative and effective pharmaceuticals within autoimmune/ inflammatory diseases and cancer where major medical need exists" 
"We promise to go the extra mile every day to ensure you receive the highest level of service and value with each shipment you entrust to us." 
"Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies" 
"To become an internationally leading dental company with innovative, proprietary products of high therapeutic and commercial value." 
"Novel products for CVD treatment and prevention." 
"We are making it more attractive for companies to invest in innovation with reduced corporation tax on profits from patents to 10%." 
"With our first class products and our committed and skilled colleagues we guarantee our customers the best support in the market, at no extra charge." 
"The PolyPeptide Group is a world class manufacturer of peptide active pharmaceutical ingredients." 
"PCG - a professional full service CRO for your clinical trials.
Powered by Viedoc, globally trusted eCRF, keeping trials within budget and timelines" 
"Our vision is to become one of the top 10 global providers of scientific instruments; we will get there by striving for market leadership in our respective product and application niches."
" 
"We have a unique technological platform, built around 5HT-receptor antagonism, for the treatment of inflammation and pain"." 
"To be acknowledged as the Best-in-Class provider of pharmaceutical development and manufacturing services by customers, employees & other stakeholders" 
"Our goal is to invest in innovations and develop new unique pharmaceuticals" 
"We help our clients create significant business value through scientific expertise." 
"We are entirely devoted to luminescence technology." 
"We turn medical research into applications for better health and well-being." 
"VWR is a global laboratory distributor of chemicals, life science products, consumables, equipment, instruments, furniture, e-commerce and services" 
"Mercodia has been a supplier of reliable assays since 1991" 
"Our reliability, customer service, global network and integrated technology make World Courier service truly "A service no one else can deliver"." 
"We offer effective staffing solutions provided by specialists, we understand a company’s specific needs and we know where to find the best talent." 
"Our products enable an increased number of transplants leading to substantial cost savings for society and increased quality of life for patients." 
"Anton Paar is a product and service leader in the field of scientific instruments. We deliver uncompromised quality in everything we do." 
"We are recognized as a flexible partner with short decision and lead times plus a proven record for the highest quality and cost efficiency." 
"Allenex is a life science company that develops, manufactures, markets and sells high quality products for the transplantation market." 
"Innovation takes place when biology meets engineering; ICT is an enabler to solve the needs for increased functionality and reduced cost in Life Science" 
"Dilafor is developing new products in the field of obstetrics, to provide an effective solution to the challenge of dystocia or protracted labor"
" 
"Your global partner of pharmaceutical service and cGMP manufacturing" 
"Discover your possibilities in one of Europe´s most productive life science regions. Welcome to Stockholm-Uppsala."
" 
"We aim to be the pioneering benchmark in user-friendly software experience in combination with the highest level of quality." 
"TFS is today the leading European development partner for biopharmaceutical companies in their global clinical development process." 
"Uppsala BIO is a life science pathfinder. We build ways to make life science flourish, in cooperation with industry, academia, society and healthcare." 
"Our aim is to be the best drug development partner to the biotechnology and pharmaceutical industry no matter where you are based." 
"Our organisation value is to contribute to positioning Scandinavian healthcare and research in absolute world class." 
"Together with Zacco our clients achieve their business goals through the management of their intellectual property." 
"To be the most attractive node and business platform in the Nordic countries for new and innovative Life Science companies" 
"Best in class companies see the value of optimising their business by having an effective strategy for information management and documentation." 
